Antithrombin Iii (THROMBOTROL-VF antithrombin III 1000IU powder for injection vial with diluent vial)
Antithrombin Iii risk profile, scheduling, and guidance for claims professionals and care workers . Also known as THROMBOTROL-VF antithrombin III 1000IU powder for injection vial with diluent vial.
Antithrombin Iii (brand names: THROMBOTROL-VF antithrombin III 1000IU powder for injection vial with diluent vial) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Hospital-use anticoagulant with bleeding risk requiring specialist monitoring.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (2 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | Not PBS listed |
Risk Profile
Hospital-use anticoagulant with bleeding risk requiring specialist monitoring.
Regulatory and Compliance Guidance
When Antithrombin Iii appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Need to assess this medication across your caseload?
Run a full risk assessment including Antithrombin Iii interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.